CorMedix Inc. to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on August 12

NEXT STORY
Global Clinical Microbiology Instruments and Reagents Market to Reach $6.1 Billion by 2027
PREV STORY
180 Life Sciences Announces Selection of Lead Synthetic CBD Analogue
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Spero Therapeutics to Present New Preclinical Data for SPR994 at ASM Microbe 2018

Eighteen presentations with data across multiple pipeline candidates including data supporting SPR994’s broad spectrum ...

author_avatar
NASDAQ Market News

BeiGene Announces Proposed Public Offering

WALTHAM, Mass., Nov. 16, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

Advaxis to Present Data at ImVacS-Immunization and Vaccine Summit on Use of Detoxified Listeriolysin O (dtLLO) as an Effective Adjuvant in Vaccine Formulations

PRINCETON, N.J., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage ...

author_avatar
NASDAQ Market News